BCD-256-1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCD-256-1, covering 2025-08-22 to 2025-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Pharmacokinetics, Immunogenicity BCD-256-1 and Divozilimab in Subjects With Systemic Lupus Erythematosus [Phase 1]